Pulmatrix Stock Analysis

Pulmatrix Stock Analysis Notes

The company has price-to-book ratio of 1.89. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Pulmatrix recorded a loss per share of 1.71. The entity last dividend was issued on the 6th of February 2019. The firm had 1:20 split on the 1st of March 2022. Pulmatrix, Inc., a clinical stage biotechnology company, discovers and develops inhaled therapies to prevent and treat respiratory and other diseases with unmet medical needs in the United States. Pulmatrix, Inc. was founded in 2003 and is headquartered in Lexington, Massachusetts. Pulmatrix operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 24 people. To find out more about Pulmatrix contact Teofilo MBA at 888 355 4440 or learn more at https://www.pulmatrix.com.

Pulmatrix Investment Alerts

Pulmatrix Largest EPS Surprises

View All Earnings Estimates

Pulmatrix Environmental, Social, and Governance (ESG) Scores

Pulmatrix Stock Institutional Investors

Note, although Pulmatrix's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Pulmatrix Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 8.95 M.

Pulmatrix Profitablity

Management Efficiency

Pulmatrix has return on total asset (ROA) of (0.4709) % which means that it has lost $0.4709 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.7947) %, meaning that it created substantial loss on money invested by shareholders. Pulmatrix's management efficiency ratios could be used to measure how well Pulmatrix manages its routine affairs as well as how well it operates its assets and liabilities. As of the 12th of February 2026, Return On Tangible Assets is likely to drop to -0.91. In addition to that, Return On Capital Employed is likely to drop to -1.02. At this time, Pulmatrix's Other Current Assets are very stable compared to the past year. As of the 12th of February 2026, Total Current Assets is likely to grow to about 21.3 M, while Non Current Assets Total are likely to drop about 19.7 K.

Technical Drivers

As of the 12th of February 2026, Pulmatrix holds the Variance of 34.5, risk adjusted performance of (0.11), and Coefficient Of Variation of (690.42). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Pulmatrix, as well as the relationship between them. Please check Pulmatrix information ratio and skewness to decide if Pulmatrix is priced some-what accurately, providing market reflects its current price of 2.38 per share. Please also confirm Pulmatrix jensen alpha, which is currently at (0.80) to check out the company can sustain itself at a future point.

Pulmatrix Price Movement Analysis

Pulmatrix Insider Trading Activities

Pulmatrix Outstanding Bonds

Pulmatrix Predictive Daily Indicators

Pulmatrix Forecast Models

Pulmatrix's time-series forecasting models are one of many Pulmatrix's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Pulmatrix's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Pulmatrix Bond Ratings

Pulmatrix financial ratings play a critical role in determining how much Pulmatrix have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Pulmatrix's borrowing costs.

Pulmatrix Debt to Cash Allocation

Pulmatrix currently holds 996 K in liabilities with Debt to Equity (D/E) ratio of 0.04, which may suggest the company is not taking enough advantage from borrowing. Pulmatrix has a current ratio of 8.03, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Pulmatrix's use of debt, we should always consider it together with its cash and equity.

Pulmatrix Accounts Payable Over Time

Pulmatrix Assets Financed by Debt

The debt-to-assets ratio shows the degree to which Pulmatrix uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

Pulmatrix Debt Ratio

28.0

It appears that most of the Pulmatrix's assets are financed through equity. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Pulmatrix's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Pulmatrix, which in turn will lower the firm's financial flexibility.

Pulmatrix Corporate Bonds Issued

Pulmatrix Short Long Term Debt Total

Stock analysis is the technique used by a trader or investor to examine and evaluate how Pulmatrix prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Pulmatrix shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Pulmatrix. By using and applying Pulmatrix Stock analysis, traders can create a robust methodology for identifying Pulmatrix entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Pulmatrix analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Pulmatrix analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Pulmatrix stock analysis indicators help investors evaluate how Pulmatrix stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Pulmatrix shares will generate the highest return on investment. By understating and applying Pulmatrix stock analysis, traders can identify Pulmatrix position entry and exit signals to maximize returns.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pulmatrix. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. To learn how to invest in Pulmatrix Stock, please use our How to Invest in Pulmatrix guide.You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

The market value of Pulmatrix is measured differently than its book value, which is the value of Pulmatrix that is recorded on the company's balance sheet. Investors also form their own opinion of Pulmatrix's value that differs from its market value or its book value, called intrinsic value, which is Pulmatrix's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Pulmatrix's market value can be influenced by many factors that don't directly affect Pulmatrix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

It's important to distinguish between Pulmatrix's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Pulmatrix should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Pulmatrix's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.